Skip to main content
. 2022 Feb 3;9:756633. doi: 10.3389/fpubh.2021.756633

Figure 1.

Figure 1

(A) total number of adverse reactions reports in EudraVigilance and VAERS by year and week. (B) number of adverse reactions reports per 100,000 persons with at least 1 COVID-19 vaccine dose (continuous line, left y-axis) and total number of persons with at least 1 dose in the EU and US by year and week (dotted lines on background, right y-axis).